Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.
Merz Therapeutics has appointed Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Staner will ...
Eli Lilly and Company has chosen the Lehigh Valley in Pennsylvania for its next manufacturing site in a $3.5 billion ...
Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), has appointed Ramani ...
Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...
Extractables and Leachables (E&L) issues are quietly derailing nearly one in five drug applications, as shown by hundreds of ...
AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.
Cell and gene therapies (CGTs) are revolutionizing treatment, but increasing regulatory scrutiny has led to a rise in costly ...
IQVIA and its Data-as-a-Service (DaaS+) technology have been chosen by Boehringer Ingelheim in a new, strategic long-term ...
Vetter, a pharmaceutical service provider for the production of injectable drugs, has announced plans to build a new ...
Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results